Baylor Charles A. Sammons Cancer Center In The News
Read the latest Baylor Charles A. Sammons Cancer Center news and stories.
4/7/2020 - As part of Kidney Cancer Awareness Month, Thomas Hutson, D.O., Pharm.D., genitourinary oncologist at Texas Oncology–Baylor Charles A. Sammons Cancer Center, discusses trends in kidney cancer diagnosis and treatment.
3/6/2020 - On International Women’s Day, observed annually on March 8, physicians from across the Texas Oncology network shared how women can take control of their health.
Publication: KTVT-TV (CBS, Dallas)
3/3/2020 - As part of a recurring series, “The Ones For Wellness,” CBS 11 spotlighted the story of Dallas-based colorectal cancer patient Danny Robertson. Suddenly fainting in front of colleagues led Danny to his first doctor's appointment in 30 years, during which he underwent his first colonoscopy at age 57, and was diagnosed with stage IV colorectal cancer that had spread to his liver.
Publication: Journal of Clinical Pathways
2/6/2020 - Scott Paulson, M.D., medical oncologist at Texas Oncology–Baylor Charles A. Sammons Cancer Center, describes the importance of a clinical pathway for stomach cancer used across the network for improving overall value for patients as well as directing practice data analyses to improve patient care.
Publication: WFAA-TV (ABC, Dallas–Fort Worth)
2/4/2020 - For David Whitson, flying planes isn’t just a job – it’s a lifelong passion. However, that passion was halted when David was diagnosed with acute myeloid leukemia and grounded by the FAA. Brian Berryman, M.D., of Texas Oncology–Baylor Charles A. Sammons Cancer Center Blood and Marrow Transplant, was featured on WFAA-TV discussing David’s diagnosis and the lengthy process he underwent to obtain clearance to fly after treatment. With the help of David’s care team, he completed treatment and was cleared by the FAA to fly again.
Publication: D CEO Healthcare
1/27/2020 - Texas Oncology subsidiary Precision Health Informatics is partnering with Concerto HealthAI to expand their precision medicine treatment of cancer patients. The collaboration will advance novel research solutions, integrating deep clinical insights derived from electronic medical record data, particularly information about the molecular basis of disease derived from tissue or liquid samples.
9/16/2019 - Texas Oncology patient Nick Heffelfinger shares how he lives well while managing chronic myeloid leukemia.
7/1/2019 - Researchers are unlocking the cellular secrets behind cancer to create promising discoveries in immunotherapy, including the latest innovation, CAR-T therapy.
6/24/2019 - Editor’s Note: Lymphoma survivor Brianna Bonnet shares her perspectives on remaining positive through multiple treatments, including CAR-T therapy.
Publication: D CEO Healthcare
6/9/2019 - Around a year ago, a partnership between Texas Oncology and Baylor University Medical Center brought groundbreaking CAR-T therapy to the Dallas community. Through CAR-T therapy, cells are modified and the patient’s immune system is used to fight cancer. Over the past year, the partnership between Texas Oncology and Baylor University Medical Center has treated 16 patients with commercially available CAR-T. Meanwhile, 30 more patients were enrolled in clinical trials for a number of different cancers. Dr. Houston Holmes, medical director and principal investigator for CAR-T clinical trials at Texas Oncology–Baylor Charles A. Sammons Cancer Center, says that the field is moving rapidly, with more than 100 different CAR-T trials right now.